Dr. Alexandra Stefanovic, MD

Dr. Stefanovic practices at Duke University Hospital in Durham, North Carolina, part of Duke University.

Dr. Stefanovic's NPI, 1033310701, was assigned on May 30, 2007. Dr. Stefanovic holds North Carolina license 2017-01236.

Dr. Stefanovic's primary practice is Duke University Hospital, at 2301 Erwin Rd, Durham, NC 27705 in Durham County. The practice phone is (919) 684-8111.

Dr. Stefanovic's primary practice is Duke University Hospital in Durham, North Carolina, part of Duke University. Dr. Stefanovic is also affiliated with Duke Regional Hospital. The medical group on file is Duke Health Integrated Practice. Dmand AI also links Dr. Stefanovic to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stefanovic practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Stefanovic's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Stefanovic is licensed in North Carolina.

CMS data shows 884 Medicare services from Dr. Stefanovic across 7 procedure codes in 2024, for 230 Medicare patients. Medicare paid $54,809 for them.

CMS counts 230 Medicare patients who saw Dr. Stefanovic in 2024. The largest group is 65 to 74, with 100 patients. 73% of them have high blood pressure, and 73% have high cholesterol. Their average risk score is 2.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Stefanovic's median patient age at 74, with 48% women.

In 2024, Dr. Stefanovic wrote 471 Medicare Part D claims for 72 patients. 41% of them were for generic drugs. CMS names the drug for 394 of them, across 12 drugs with 11 or more claims each, at $3,594,976 in total drug cost. In 2023, CMS named 165 claims across 5 drugs.

Dr. Stefanovic accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Stefanovic as offering telehealth.

Dmand AI links 12 papers to Dr. Stefanovic, published from 2010 to 2021. 2010 was the busiest year, with 2. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Lymphoproliferative Disorders and Rituximab. Dr. Stefanovic has published most often in Am J Hematol. Dr. Stefanovic's most frequent co-authors are Izidore Lossos, MD, Juan Pablo Alderuccio, MD and James Edward Hoffman, MD.

CMS Open Payments shows 67 general payments to Dr. Stefanovic from 22 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 58% of the total. Cardinal Health, Inc. paid the most, $2,662.